• SENSEX 74,315.61
    1,533.72 (+2.11%)
  • BANKNIFTY 55,810.50
    494.50 (+0.89%)
  • Reliance Industries
    1,223.30 1,611.20(%)
  • NSE
    1,777.00 1,878.00(%)
  • TCS
    2,386.70 3,336.70(%)
  • HCL Technologies
    1,376.00 1,770.00(%)
  • HDFC Bank
    728.55 1,020.35(%)
  • Infosys
    1,126.40 1,727.85(%)
  • Indian Hotels Co
    752.50 757.10(%)
  • Gallantt Ispat L
    648.45 946.70(%)
  • ICICI Bank
    1,395.00 1,479.90(%)
  • NMDC
    70.56 70.15(%)
  • Billionbrains
    200.85 227.00(%)
  • Axis Bank
    1,294.40 1,418.30(%)
  • Netweb Technol.
    4,666.00 2,942.45(%)
  • Bajaj Finance
    975.00 1,177.60(%)
  • HDB FINANC SER
    536.65 536.65(%)
  • Bharti Airtel
    1,871.20 2,174.70(%)
  • SS Retail
    741.55 603.00(%)
  • Eternal
    324.35 368.40(%)
  • Kotak Mah. Bank
    448.85 452.98(%)
  • MV Electrosystems
    918.00 510.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Orchid Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3135.0
  • ISIN : INE191A01027
928.05 -17 (-1.82%)
  • As on 15 Oct 2026 (EOD)

  • Today’s Low

    925.00

  • Today’s High

    950.25

  • Open

    945.25

  • Perv Close

    945.25

  • 52W Low

    480.00

  • 52W High

    1,143.50

Key Indicators

  • P/E(TTM)

    114.76

  • Mar.Cap (₹Cr.)

    5,557.65

  • Div & Yield %

    0.00

  • Book Value(₹)

    274.97

  • Debt-Equity Ratio

    -1.82

  • AGM Date

    15-Oct-2026

  • EPS

    8.07

  • P/E Ratio

    114.76

Financials Ratios

  • Debt-Equity Ratio

    0.25

  • Mar.Cap (₹Cr.)

    5,557.65

  • RONW (%)

    3.02

  • ROCE (%)

    3.20

Score Board

  • Equity (₹ in Cr.)

    59.89

  • BV (₹)

    275.00

  • Sales( ₹ in Cr.)

    1,232.78

  • NP (in Cr.)

    47.24

  • NP Var(%)

    -68.0

  • Div%

    0.0

  • CPS (₹)

    15.10

  • EPS (₹)

    7.90

  • Traded Value (₹ in Lakhs)

    5,546.27

  • 52 Week High

    1,143.50

  • 52 Week Low

    480.00

  • Price BSE

    926.0

  • Price NSE

    928.00

  • Market Capital( in Cr.)

    5,546.27

  • P/C Ratio

    61.20

  • P/E Ratio

    117.40

  • Price Vs.BV

    7.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,232.78 1,397.61 819.37 665.90 556.97 450.70
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,232.78 1,397.61 819.37 665.90 556.97 450.70
Other Income 56.49 36.43 30.39 58.64 56.97 6.46
Stock Adjustments -71.38 21.95 43.89 21.48 22.73 15.69
Total Income 1,217.89 1,455.99 893.65 746.02 636.67 472.85
EXPENDITURE :            
Raw Materials 773.08 915.30 528.35 406.10 336.80 244.96
Power and Fuel Cost 89.62 100.07 62.92 61.26 52.74 39.31
Employee Cost 114.32 109.23 69.64 65.35 60.21 64.40
Other Manufacturing Expenses 47.89 51.91 32.65 29.19 26.26 24.26
Selling and Administration Expenses 66.80 73.41 53.17 34.96 37.77 31.58
Miscellaneous Expenses 38.89 18.47 5.46 7.28 7.22 24.38
Employee Benefit Expenses 114.32 109.23 69.64 65.35 60.21 64.40
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,130.59 1,268.38 752.20 604.14 521.00 428.89
Operating Profit 87.30 187.61 141.45 141.88 115.67 43.96
Interest 9.32 13.25 16.71 32.90 33.46 52.21
Gross Profit 77.98 174.36 124.74 108.98 82.21 -8.25
Depreciation 43.36 41.91 33.22 54.79 87.02 108.90
Profit Before Tax 34.62 132.45 91.52 54.19 -4.81 -117.15
Current Tax 0.00 0.23 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 -9.69 -3.23 0.00 0.00 0.00
Reported Net Profit 34.62 141.90 94.75 54.19 -4.81 -117.15
Extraordinary Items -12.62 -5.89 -0.19 40.00 0.51 0.98
Adjusted Net Profit 47.24 147.79 94.94 14.19 -5.32 -118.13
Adjustment below Net Profit 0.00 238.80 0.00 0.00 0.00 0.00
P & L Balance brought forward -1,608.38 -1,988.38 -2,082.68 -2,136.64 -2,133.29 -2,016.74
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations -1.18 0.70 0.45 0.23 -1.46 -0.60
P & L Balance carried down -1,572.58 -1,608.38 -1,988.38 -2,082.68 -2,136.64 -2,133.29
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 22.63 92.75 18.68 13.28 -1.18 -28.70
Earnings Per Share(Adj)-Unit Curr 22.63 92.75 18.68 13.28 -1.18 -28.70
Book Value 1,047.18 1,023.69 226.69 162.53 149.30 150.13
Book Value(Adj)-Unit Curr 1,047.18 1,023.69 226.69 162.53 149.30 150.13

Shareholding Pattern

  • Promoter Group

    74.45%

  • Public Share Holding

    25.55%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 19,254,312 32.15 19,254,312 21
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 25,331,740 42.30 25,331,740 2
Others 0 0.00 0 0
Sub Total 44,586,052 74.45 44,586,052 23
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 32,440 0.05 32,440 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 554,178 0.93 554,178 30
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 2,396 0.00 2,396 1
Insurance Companies 3,961 0.01 3,961 3
Mutual Funds / UTI 10,123,584 16.91 10,123,584 10
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 345,085 0.58 345,085 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 11,061,644 18.47 11,061,644 54
2] Non Institution
Bodies Corporate 794,476 1.33 791,238 388
Clearing Members 217 0.00 217 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 211,110 0.35 211,110 610
Foreign Non Institution Other 68 0.00 68 1
Hindu Undivided Families 136,529 0.23 136,529 957
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 458,525 0.77 458,525 17
Individuals holding nominal share capital up to Rs. 1 lakh 2,608,957 4.36 2,608,687 31,202
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 26,987 0.05 26,987 2
Others 635 0.00 635 3
Sub Total 4,237,504 7.08 4,233,996 33,183
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 59,885,200 100.00 59,881,692 33,260

Company Background

Orchid Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Orchid Pharma Ltd
  • BSE Code : 3135.0
  • ISIN : INE191A01027

  • Incorporation Year

    1992

  • Registered Office

    Orchid Towers Nungambakkam
    313 Valluvar Kottam High Road, Chennai,
    Tamil Nadu-600034

  • Telephone

    91-44-28211000/28230000

  • FAX

    91-44-28211002

  • Chairman

    R G Agarwal

  • Managing Director

  • Company Secretary

    Kapil Dayya

  • Auditor

    Singhi & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar


    ,
    ,
    Mumbai -

Orchid Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Orchid Pharma 926.15 1,289.27 1,232.78 135.20 1.68
Abbott India 26,068.45 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 5,922.60 2,304.07 2,275.58 87.29 27.86
Glaxosmi. Pharma 2,523.00 3,932.76 3,790.20 40.30 58.17
Novartis India 1,937.30 393.10 354.33 48.92 15.94
Cipla 1,333.70 20,102.60 18,979.95 35.05 13.88
Bliss GVS Pharma 655.95 773.53 729.81 60.96 12.51
Amrutanjan Healt 506.40 520.13 502.55 27.12 24.16
Fermenta Biotec. 486.65 474.15 450.25 22.72 18.77
Guj. Themis Bio. 370.70 168.25 165.82 99.12 18.05
Ambalal Sarabhai 38.15 19.52 3.94 70.65 6.77